vs
Side-by-side financial comparison of Ceribell, Inc. (CBLL) and PEOPLES BANCORP OF NORTH CAROLINA INC (PEBK). Click either name above to swap in a different company.
Ceribell, Inc. is the larger business by last-quarter revenue ($24.8M vs $21.5M, roughly 1.2× PEOPLES BANCORP OF NORTH CAROLINA INC). PEOPLES BANCORP OF NORTH CAROLINA INC runs the higher net margin — 30.8% vs -54.6%, a 85.4% gap on every dollar of revenue. PEOPLES BANCORP OF NORTH CAROLINA INC produced more free cash flow last quarter ($20.0M vs $-11.0M).
Ceribell, Inc. develops and commercializes innovative portable neurodiagnostic medical devices, focused on rapid non-invasive electroencephalogram (EEG) solutions for seizure detection. Its core products serve hospital emergency departments, intensive care units, and long-term care facilities, with primary markets across North America and ongoing global expansion efforts.
PEOPLES BANCORP OF NORTH CAROLINA INC is a regional bank holding company headquartered in North Carolina, U.S. It offers a full suite of personal and commercial banking services including deposit accounts, consumer and business loans, mortgage services, and wealth management solutions, primarily serving local residents, small and medium-sized enterprises, and community organizations across its operating areas in North Carolina.
CBLL vs PEBK — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $24.8M | $21.5M |
| Net Profit | $-13.5M | $6.6M |
| Gross Margin | 87.3% | — |
| Operating Margin | -58.9% | 40.7% |
| Net Margin | -54.6% | 30.8% |
| Revenue YoY | — | 5.6% |
| Net Profit YoY | — | 86.4% |
| EPS (diluted) | $-0.35 | $1.21 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $24.8M | $21.5M | ||
| Q3 25 | $22.6M | $21.4M | ||
| Q2 25 | $21.2M | $20.7M | ||
| Q1 25 | $20.5M | $20.0M | ||
| Q4 24 | — | $20.4M | ||
| Q3 24 | $17.2M | $20.5M | ||
| Q2 24 | — | $20.1M | ||
| Q1 24 | — | $19.8M |
| Q4 25 | $-13.5M | $6.6M | ||
| Q3 25 | $-13.5M | $3.7M | ||
| Q2 25 | $-13.6M | $5.2M | ||
| Q1 25 | $-12.8M | $4.3M | ||
| Q4 24 | — | $3.6M | ||
| Q3 24 | $-10.4M | $4.0M | ||
| Q2 24 | — | $4.9M | ||
| Q1 24 | — | $3.9M |
| Q4 25 | 87.3% | — | ||
| Q3 25 | 88.3% | — | ||
| Q2 25 | 88.1% | — | ||
| Q1 25 | 87.9% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 87.3% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -58.9% | 40.7% | ||
| Q3 25 | -64.8% | 22.4% | ||
| Q2 25 | -70.5% | 32.2% | ||
| Q1 25 | -69.3% | 28.2% | ||
| Q4 24 | — | 22.5% | ||
| Q3 24 | -57.8% | 26.0% | ||
| Q2 24 | — | 31.3% | ||
| Q1 24 | — | 23.9% |
| Q4 25 | -54.6% | 30.8% | ||
| Q3 25 | -59.6% | 17.2% | ||
| Q2 25 | -64.4% | 24.9% | ||
| Q1 25 | -62.4% | 21.8% | ||
| Q4 24 | — | 17.5% | ||
| Q3 24 | -60.6% | 19.3% | ||
| Q2 24 | — | 24.4% | ||
| Q1 24 | — | 19.9% |
| Q4 25 | $-0.35 | $1.21 | ||
| Q3 25 | $-0.37 | $0.67 | ||
| Q2 25 | $-0.38 | $0.95 | ||
| Q1 25 | $-0.36 | $0.79 | ||
| Q4 24 | — | $0.65 | ||
| Q3 24 | $-1.85 | $0.72 | ||
| Q2 24 | — | $0.89 | ||
| Q1 24 | — | $0.72 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $159.3M | $58.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $155.3M | $157.1M |
| Total Assets | $195.8M | $1.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $159.3M | $58.1M | ||
| Q3 25 | $168.5M | — | ||
| Q2 25 | $177.4M | — | ||
| Q1 25 | $182.7M | — | ||
| Q4 24 | — | $59.3M | ||
| Q3 24 | $14.1M | $73.2M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $155.3M | $157.1M | ||
| Q3 25 | $164.1M | $149.5M | ||
| Q2 25 | $172.2M | $144.0M | ||
| Q1 25 | $180.9M | $138.5M | ||
| Q4 24 | — | $130.6M | ||
| Q3 24 | $-136.0M | $136.3M | ||
| Q2 24 | — | $124.3M | ||
| Q1 24 | — | $121.1M |
| Q4 25 | $195.8M | $1.7B | ||
| Q3 25 | $199.5M | $1.7B | ||
| Q2 25 | $207.7M | $1.7B | ||
| Q1 25 | $213.5M | $1.7B | ||
| Q4 24 | — | $1.7B | ||
| Q3 24 | $47.1M | $1.7B | ||
| Q2 24 | — | $1.7B | ||
| Q1 24 | — | $1.7B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $-10.8M | $21.4M |
| Free Cash FlowOCF − Capex | $-11.0M | $20.0M |
| FCF MarginFCF / Revenue | -44.2% | 92.7% |
| Capex IntensityCapex / Revenue | 0.7% | 6.6% |
| Cash ConversionOCF / Net Profit | — | 3.22× |
| TTM Free Cash FlowTrailing 4 quarters | $-41.6M | $34.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-10.8M | $21.4M | ||
| Q3 25 | $-11.1M | $4.7M | ||
| Q2 25 | $-7.5M | $5.5M | ||
| Q1 25 | $-11.4M | $5.9M | ||
| Q4 24 | — | $20.6M | ||
| Q3 24 | — | $4.9M | ||
| Q2 24 | — | $6.7M | ||
| Q1 24 | — | $3.7M |
| Q4 25 | $-11.0M | $20.0M | ||
| Q3 25 | $-11.5M | $4.4M | ||
| Q2 25 | $-7.6M | $5.4M | ||
| Q1 25 | $-11.6M | $5.2M | ||
| Q4 24 | — | $20.0M | ||
| Q3 24 | — | $4.7M | ||
| Q2 24 | — | $6.6M | ||
| Q1 24 | — | $3.5M |
| Q4 25 | -44.2% | 92.7% | ||
| Q3 25 | -50.8% | 20.4% | ||
| Q2 25 | -35.9% | 25.9% | ||
| Q1 25 | -56.4% | 25.8% | ||
| Q4 24 | — | 98.0% | ||
| Q3 24 | — | 22.9% | ||
| Q2 24 | — | 32.7% | ||
| Q1 24 | — | 17.9% |
| Q4 25 | 0.7% | 6.6% | ||
| Q3 25 | 1.6% | 1.5% | ||
| Q2 25 | 0.3% | 0.5% | ||
| Q1 25 | 0.7% | 3.8% | ||
| Q4 24 | — | 2.9% | ||
| Q3 24 | — | 1.0% | ||
| Q2 24 | — | 0.4% | ||
| Q1 24 | — | 0.6% |
| Q4 25 | — | 3.22× | ||
| Q3 25 | — | 1.27× | ||
| Q2 25 | — | 1.06× | ||
| Q1 25 | — | 1.36× | ||
| Q4 24 | — | 5.78× | ||
| Q3 24 | — | 1.24× | ||
| Q2 24 | — | 1.36× | ||
| Q1 24 | — | 0.93× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CBLL
| Products | $18.8M | 76% |
| Subscription | $6.0M | 24% |
PEBK
Segment breakdown not available.